INNOVANCE Antithrombin AssayState-of-the-art antithrombin testing

 

The INNOVANCE® Antithrombin Assay is a state-of-the-art reagent for the detection of congenital or acquired antithrombin deficiencies. The ready-to-use reagent offers improved onboard stability and, due to its Xa-based activity, shows excellent sensitivity to detect antithrombin mutations.

Features & Benefits


Stable reagents
  • Good method correlation offers harmonized result interpretation and helps avoid the need for repeat testing, saving time and reagents.
  • Available in different ready-to-use kit sizes, reducing waste and providing cost and labor efficiencies.

Fast turnaround time
  • Ready-to-use liquid reagent provides excellent precision and uses standard calibrators and controls for simplified system adaption.
  • Available for any sized lab on the BCS® XP System, Sysmex® CA-600 and CS Systems, and Atellica® COAG 360 System1

Validated diagnostic
  • The ready-to-use reagent offers improved onboard stability and, due to its Xa-based activity, shows excellent sensitivity to detect antithrombin mutations.2

Technical Specifications

10 µL
Required sample volume, depending on system application

0–140% of norm
Measuring range on BCS XP System

48 hours
Onboard stability on BCS® XP System

3.7%
Within-device/lab CV (%) of Control Plasma N on BCS XP System

100/430 tests per kit3
Number of tests per kit for small/large kit configuration

4 weeks
Stability after reconstitution at 2–8°C

Clinical Use


GTH COVID-19 treatment recommendations

GTH COVID-19 treatment recommendations

Hospitalized patients with SARS-CoV-2 infection should be continually monitored. Reasonable laboratory parameters include D-dimer, prothrombin time (Quick/INR), platelet count, fibrinogen, and antithrombin.4,5

1
2
3
4
5